Cite
HARVARD Citation
Purcell, J. et al. (n.d.). ABBV-085 is a novel antibody–drug conjugate (ADC) that targets LRRC15 in the tumor microenvironment. European journal of cancer. pp. S10-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Purcell, J. et al. (n.d.). ABBV-085 is a novel antibody–drug conjugate (ADC) that targets LRRC15 in the tumor microenvironment. European journal of cancer. pp. S10-. [Online].